{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:53:37Z","timestamp":1769151217026,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00417-021-05211-2","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T05:42:43Z","timestamp":1622526163000},"page":"3243-3250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion"],"prefix":"10.1007","volume":"259","author":[{"given":"Hongfang","family":"Yong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"8","key":"5211_CR1","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/eye.2011.92","volume":"25","author":"M Laouri","year":"2011","unstructured":"Laouri M, Chen E, Looman M, Gallagher M (2011) The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 25(8):981\u2013988. https:\/\/doi.org\/10.1038\/eye.2011.92","journal-title":"Eye (Lond)"},{"issue":"2","key":"5211_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1167\/iovs.14-15789","volume":"56","author":"H Noma","year":"2015","unstructured":"Noma H, Mimura T, Yasuda K, Shimura M (2015) Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema. Invest Ophthalmol Vis Sci 56(2):1122\u20131128. https:\/\/doi.org\/10.1167\/iovs.14-15789","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5211_CR3","doi-asserted-by":"publisher","first-page":"4936924","DOI":"10.1155\/2017\/4936924","volume":"2017","author":"J Li","year":"2017","unstructured":"Li J, Paulus YM, Shuai Y, Fang W, Liu Q (2017) New developments in the classification, pathogenesis, risk factors, natural history, and treatment of branch retinal vein occlusion. J Ophthalmol 2017:4936924. https:\/\/doi.org\/10.1155\/2017\/4936924","journal-title":"J Ophthalmol"},{"key":"5211_CR4","doi-asserted-by":"publisher","first-page":"432685","DOI":"10.1155\/2014\/432685","volume":"2014","author":"FJ Ascaso","year":"2014","unstructured":"Ascaso FJ, Huerva V (2014) The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases. Mediators Inflamm 2014:432685. https:\/\/doi.org\/10.1155\/2014\/432685","journal-title":"Mediators Inflamm"},{"key":"5211_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.preteyeres.2017.10.006","volume":"63","author":"A Daruich","year":"2018","unstructured":"Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild PR, Omri S, Gelize E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, Behar-Cohen F (2018) Mechanisms of macular edema: Beyond the surface. Prog Retin Eye Res 63:20\u201368. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.10.006","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"5211_CR6","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1111\/aos.12510","volume":"93","author":"XR Hou","year":"2015","unstructured":"Hou XR, Miao H, Tao Y, Li XX, Wong IY (2015) Expression of cytokines on the iris of patients with neovascular glaucoma. Acta Ophthalmol 93(2):e100-104. https:\/\/doi.org\/10.1111\/aos.12510","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"5211_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye (Lond) 22(1):42\u201348. https:\/\/doi.org\/10.1038\/sj.eye.6702498","journal-title":"Eye (Lond)"},{"key":"5211_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","volume":"49","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA (2015) Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 49:67\u201381. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.06.002","journal-title":"Prog Retin Eye Res"},{"key":"5211_CR9","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1038\/cddis.2013.303","volume":"4","author":"M Cachafeiro","year":"2013","unstructured":"Cachafeiro M, Bemelmans AP, Samardzija M, Afanasieva T, Pournaras JA, Grimm C, Kostic C, Philippe S, Wenzel A, Arsenijevic Y (2013) Hyperactivation of retina by light in mice leads to photoreceptor cell death mediated by VEGF and retinal pigment epithelium permeability. Cell Death Dis 4:e781. https:\/\/doi.org\/10.1038\/cddis.2013.303","journal-title":"Cell Death Dis"},{"issue":"2","key":"5211_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","volume":"131","author":"H Noma","year":"2013","unstructured":"Noma H, Mimura T, Eguchi S (2013) Association of inflammatory factors with macular edema in branch retinal vein occlusion. JAMA ophthalmology 131(2):160\u2013165. https:\/\/doi.org\/10.1001\/2013.jamaophthalmol.228","journal-title":"JAMA ophthalmology"},{"key":"5211_CR11","doi-asserted-by":"publisher","unstructured":"Noma H, Funatsu H, Mimura T (2013) Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion. J Ocul Pharmacol Ther 29:363\u2013365. https:\/\/doi.org\/10.1089\/jop.2011.0222","DOI":"10.1089\/jop.2011.0222"},{"issue":"7","key":"5211_CR12","doi-asserted-by":"publisher","first-page":"e68149","DOI":"10.1371\/journal.pone.0068149","volume":"8","author":"J Feng","year":"2013","unstructured":"Feng J, Zhao T, Zhang Y, Ma Y, Jiang Y (2013) Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion. PLoS ONE 8(7):e68149. https:\/\/doi.org\/10.1371\/journal.pone.0068149","journal-title":"PLoS ONE"},{"issue":"6","key":"5211_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1755-3768.2009.01524.x","volume":"88","author":"H Noma","year":"2010","unstructured":"Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S (2010) Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol 88(6):646\u2013651. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01524.x","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"5211_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/tvst.8.5.32","volume":"8","author":"M Mesquida","year":"2019","unstructured":"Mesquida M, Drawnel F, Lait PJ, Copland DA, Stimpson ML, Llorenc V, Sainz de la Maza M, Adan A, Widmer G, Strassburger P, Fauser S, Dick AD, Lee RWJ, Molins B (2019) Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood-Retinal Barrier Integrity In Vitro. Transl Vis Sci Technol 8(5):32. https:\/\/doi.org\/10.1167\/tvst.8.5.32","journal-title":"Transl Vis Sci Technol"},{"key":"5211_CR15","doi-asserted-by":"publisher","first-page":"5185128","DOI":"10.1155\/2019\/5185128","volume":"2019","author":"H Noma","year":"2019","unstructured":"Noma H, Yasuda K, Shimura M (2019) Cytokines and the pathogenesis of macular edema in branch retinal vein occlusion. J Ophthalmol 2019:5185128. https:\/\/doi.org\/10.1155\/2019\/5185128","journal-title":"J Ophthalmol"},{"issue":"7","key":"5211_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/eye.2009.340","volume":"24","author":"A Fonollosa","year":"2010","unstructured":"Fonollosa A, Garcia-Arumi J, Santos E, Macia C, Fernandez P, Segura RM, Zapata MA, Rodriguez-Infante R, Boixadera A, Martinez-Castillo V (2010) Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion. Eye (Lond) 24(7):1284\u20131290. https:\/\/doi.org\/10.1038\/eye.2009.340","journal-title":"Eye (Lond)"},{"issue":"2","key":"5211_CR17","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1111\/j.1755-3768.2011.02292.x","volume":"90","author":"MJ Koss","year":"2012","unstructured":"Koss MJ, Pfister M, Rothweiler F, Michaelis M, Cinatl J, Schubert R, Koch FH (2012) Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion. Acta Ophthalmol 90(2):e98\u2013e103. https:\/\/doi.org\/10.1111\/j.1755-3768.2011.02292.x","journal-title":"Acta Ophthalmol"},{"key":"5211_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2147\/opth.s163859","volume":"12","author":"JM Jumper","year":"2018","unstructured":"Jumper JM, Dugel PU, Chen S, Blinder KJ, Walt JG (2018) Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2). Clin Ophthalmol (Auckland, NZ) 12:621\u2013629. https:\/\/doi.org\/10.2147\/opth.s163859","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"6","key":"5211_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.22608\/apo.2017459","volume":"6","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Mieler WF (2017) Update on the Use of Anti-VEGF Intravitreal Therapies for Retinal Vein Occlusions. Asia Pac J Ophthalmol (Philadelphia, Pa) 6(6):546\u2013553. https:\/\/doi.org\/10.22608\/apo.2017459","journal-title":"Asia Pac J Ophthalmol (Philadelphia, Pa)"},{"issue":"20","key":"5211_CR20","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1001\/jama.2017.4568","volume":"317","author":"IU Scott","year":"2017","unstructured":"Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J (2017) Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial. JAMA 317(20):2072\u20132087. https:\/\/doi.org\/10.1001\/jama.2017.4568","journal-title":"JAMA"},{"issue":"6","key":"5211_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2174\/1566524015666150731100012","volume":"15","author":"W Chen","year":"2015","unstructured":"Chen W, Zhao B, Jiang R, Zhang R, Wang Y, Wu H, Gordon L, Chen L (2015) Cytokine expression profile in aqueous humor and sera of patients with acute anterior uveitis. Curr Mol Med 15(6):543\u2013549","journal-title":"Curr Mol Med"},{"issue":"3","key":"5211_CR22","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1111\/aos.12219","volume":"92","author":"HJ Sohn","year":"2014","unstructured":"Sohn HJ, Han DH, Lee DY, Nam DH (2014) Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion. Acta Ophthalmol 92(3):e217-224. https:\/\/doi.org\/10.1111\/aos.12219","journal-title":"Acta Ophthalmol"},{"key":"5211_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12950-019-0214-2","volume":"16","author":"A Mashima","year":"2019","unstructured":"Mashima A, Noma H, Yasuda K, Goto H, Shimura M (2019) Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion. J Inflamm (London, England) 16:9. https:\/\/doi.org\/10.1186\/s12950-019-0214-2","journal-title":"J Inflamm (London, England)"},{"key":"5211_CR24","doi-asserted-by":"publisher","first-page":"5831682","DOI":"10.1155\/2017\/5831682","volume":"2017","author":"A Pielen","year":"2017","unstructured":"Pielen A, Buhler AD, Heinzelmann SU, Bohringer D, Ness T, Junker B (2017) Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa. J Ophthalmol 2017:5831682. https:\/\/doi.org\/10.1155\/2017\/5831682","journal-title":"J Ophthalmol"},{"issue":"3","key":"5211_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000442258","volume":"55","author":"C Chiquet","year":"2016","unstructured":"Chiquet C, Bron AM, Straub M, Dupuy C, Isaico R, Aptel F, Creuzot-Garcher C (2016) Retinal vein occlusions: therapeutic switch in macular oedema treatment with a 12-month follow-up. Ophthalmic Res 55(3):152\u2013158. https:\/\/doi.org\/10.1159\/000442258","journal-title":"Ophthalmic Res"},{"issue":"2","key":"5211_CR26","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1111\/aos.13152","volume":"95","author":"S Rezar-Dreindl","year":"2017","unstructured":"Rezar-Dreindl S, Eibenberger K, Pollreisz A, Buhl W, Georgopoulos M, Krall C, Dunavolgyi R, Weigert G, Kroh ME, Schmidt-Erfurth U, Sacu S (2017) Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion. Acta Ophthalmol 95(2):e119\u2013e127. https:\/\/doi.org\/10.1111\/aos.13152","journal-title":"Acta Ophthalmol"},{"key":"5211_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/opth.s149935","volume":"12","author":"M Takeyama","year":"2018","unstructured":"Takeyama M, Takeuchi F, Gosho M, Sugita K, Zako M, Iwaki M, Kamei M (2018) Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes. Clin Ophthalmol (Auckland, NZ) 12:35\u201341. https:\/\/doi.org\/10.2147\/opth.s149935","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"3","key":"5211_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.18240\/ijo.2018.03.13","volume":"11","author":"XX Feng","year":"2018","unstructured":"Feng XX, Li C, Shao WW, Yuan YG, Qian XB, Zheng QS, Li YJ, Gao QY (2018) Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report. Int J Ophthalmol 11(3):429\u2013437. https:\/\/doi.org\/10.18240\/ijo.2018.03.13","journal-title":"Int J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05211-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T06:24:15Z","timestamp":1634538255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05211-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5211"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05211-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"23 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There were no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Second Hospital of Jilin University (No.2018\u2013282) and was conducted in compliance with the Declaration of Helsinki. Informed signed consent was provided by all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}